Your Article Summary
A Live-Attenuated Vaccine for the Treatment of Urinary Tract Infection by Uropathogenic Escherichia coli
The Journal of Infectious Diseases, 06/19/09
Billips BK et al. - NU14 delta-waaL is a candidate live-attenuated vaccine for the treatment and prevention of acute and recurrent urinary tract infection by caused by uropathogenic E. coli.
Related Articles
Urinary tract infections in pediatric renal transplant recipients
Pediatric Transplantation, 11/06/09
Relevance Score: 84%
Hygiene and urinary tract infections after cystectomy in 452 Swedish survivors of bladder cancer
BJU International, 11/02/09
Relevance Score: 84%
Serum Procalcitonin for Prediction of Renal Parenchymal Involvement in Children with Urinary Tract Infections
The Journal of Pediatrics, 11/02/09
Relevance Score: 84%
Prevalence of lower urinary tract infection in South Indian type 2 diabetic subjects
Indian Journal of Nephrology, 10/16/09
Relevance Score: 84%
Automated Microscopy, Dipsticks and the Diagnosis of Urinary Tract Infection
BMJ - Archives of Diseases in Childhood, 10/30/09
Relevance Score: 80%
Today in Infections/STDs...keeping you current
Receive free subspecialty "5-minute updates" via email
The International Index of Erectile Function: Development of an Adapted Tool for Use in HIV-Positive Men Who Have Sex with Men
The Journal of Sexual Medicine, 12/07/09
Lower risk of urinary tract infection with low-dose trimethoprim/sulfamethoxazole compared to dapsone prophylaxis in older renal transplant patients on a rapid steroid-withdrawal immunosuppression regimen
Clinical Transplantation, 12/07/09
Fibroblast growth factor-inducible 14 (Fn14) is expressed in the lower genital tract and may play a role in amplifying inflammation during infection
Journal of Reproductive Immunology, 12/07/09

See Latest Articles